Candidates for Chair

Robert W. Atcher, Los Alamos National Laboratory ( , received his B.A. in Chemistry from Washington University, St. Louis, (1972), a Masters in Journalism (Science Writing) from the Univ. of Missouri (1976) and his PhD in Nuclear Chemistry from the University of Rochester (1980). He holds the Master of Business Administration from the Univ. of New Mexico (2004). He was a postdoctoral fellow at Harvard Medical School and promoted to Research Associate (1979-1983). In 1983, he moved to the National Cancer Institute where he was a Cancer Expert in the Radiation Oncology Branch. He was appointed to Argonne National Laboratory in 1986 where he served as group leader for nuclear medicine research in the Chemistry Division. He held a joint appointment in as Asst. Professor of Radiation Oncology at the Univ. of Chicago. He was recruited to the Univ. of Alabama at Birmingham in 1994 to lead the effort to establish the National Biomedical Tracer Facility, a dedicated cyclotron for isotope production. He held appointments as Professor in the Departments of Radiation Oncology and Medicine. In 1997, he moved to Los Alamos National Laboratory to work on the Isotope Production Facility construction and operation. He was appointed the University of New Mexico/Los Alamos National Laboratory Professor of Pharmacy in 2000 where he is also a member of the Cancer Research and Treatment Center. At LANL, he has held a variety of positions in line and program management. In 2009, he was appointed director of the National Isotope Development Center, a virtual center to support the US Dept. of Energy Isotope Development and Production for Research and Applications program in the Office of Nuclear Physics. He recently completed his tenure at NIDC director. From 2008-9, he was President of the Society of Nuclear Medicine where he has chaired several committees including Government Relations and the Awards Commmittee. He currently serves as the chair of the task group on Medical Isotope Availability. He is the Editor at Large for Molecular Imaging Insight. He has been a member of the American Chemical Society since 1983 in both the Divisions of Nuclear Chemistry and Technology and Inorganic Chemistry. He was on the founding Editorial Board for Bioconjugate Chemistry. He chaired the NUCL Seaborg Award Committee. He currently serves on the Nuclear Science Advisory Committee for DOE and NSF. He is also a member of the Long Range Planning Committee for the Office of Nuclear Physics at DOE. He has served on numerous committees and panels for the Dept. of Energy, National Institutes of Health and other Federal and International agencies. He is a Fellow of the American Institute of Chemists. He is a member of the board of directors of the Education and Research Foundation for the Society of Nuclear Medicine. He is also a member of the American Physical Society where he serves on the program committee for the Division of Nuclear Physics. He has published over 90 peer-reviewed papers, presented 80 abstracts at national and international meetings, and given 150 invited lectures. He holds 6 patents and has one in process. His research interests include the production of radionuclides for a variety of applications by accelerator, reactor and long-lived parent isotopes; the development of radiopharmaceuticals for the diagnosis and treatment of human disease; and public policy for the development of nuclear science. He consults for a variety of companies from start-ups to Fortune 100 members.

Laetitia H. Delmau, Oak Ridge National Laboratory (, is a Research Staff member in the Chemical Separations Group of the Chemical Sciences Division at Oak Ridge National Laboratory. She graduated with an Engineering degree in 1994 from the Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris, France, a Post-Master degree in radiochemistry from University of Paris VI, France (1994), and her Ph.D. in physical chemistry at the University of Strasbourg, France in 1997. After a postdoctoral fellowship in the Chemical Separations group at ORNL (1997-2000), she was promoted to her current position. She is the author/co-author of >31 peer-reviewed journal articles, five patents, and has mentored numerous postdoctoral, graduate, and undergraduate researchers. She has served as the lead PI on several research projects and contracts. Her current research interests include: separations chemistry, solvent extraction and ion exchange, solution thermodynamics, actinide chemistry, nuclear fuel reprocessing, radioactive waste treatment, and chemical recognition phenomena She has been a member of ACS, the I&EC Division, and the NUCL Division since 1998. She has co-organized 4 division symposia at ACS national meetings. She is currently the treasurer of the Separation Science and Technology subdivision of the I&EC and has been the Newsletter editor for the NUCL Division for about 10 years.

Candidates for Councilor

Michael G. Bronikowski, Savannah River National Laboratory (michael.bronikowski@SRNL.DOE.GOV), was educated at Marquette University (BS, Chemistry, 1984) and Purdue University (Ph.D., Nuclear Chemistry, 1994) where he studied ultra relativistic heavy ion reactions. He took a postdoctoral appointment at Florida State University (1995-1998) to study actinide complexation with organic ligands in concentrated brine. In 1998 he joined the staff at SRNL as a senior scientist in the actinide technology section and is now a principal scientist (2004-present) in the nonproliferation technologies section. He is an Adjunct Assistant Professor in the Department of Environmental Engineering and Earth Sciences at Clemson University (2000-present) and served on the Environmental Health Physics Advisory board (2005-2009) at Clemson. He has held elected positions in the ACS Savannah River local section 2006-present (Chair, 2007) During this time the section ran SERMACS (2006), and won luminary awards for “outstanding performance by a local section”(2006) and the “ACS Presidents award for local government affairs (2007)” On the ACS national level he has been a NUCL member since 1986, an IE&C member since 1996. He co-organized NUCL divisional symposia, and worked on the NUCL “strategic plan” (2007) and with helped with the present plans educational response. He has held the NUCL positions of vice chair (2009), chair elect (2010), chair & program chair (2011) and past chair (2012). Presently, he is on the ACS Seaborg Canvassing committee (2013-2015) and Program Co-Chair for SERMACS 2018. His research interests include: Nuclear reactions, radiochemical separations, as well as separations, process, and environmental chemistry of the actinides.

Graham F. Peaslee, Hope College (, obtained his undergraduate degree from Princeton University (AB, Chemistry, 1981) and his graduate degree from SUNY – Stony Brook (Ph.D., Chemical Physics, 1987). He took post-doctoral appointments at Lawrence Berkeley Laboratory (1988-1990) and the National Superconducting Cyclotron Laboratory (1990-1993). In 1993 he joined the Chemistry Department at Hope College in Holland, MI. He was promoted to Associate Professor in 2000, and promoted to full Professor in 2007. In 2011 he was named the Hartgerink Professor of Chemistry. In 2000-2001 he was a visiting scientist at the Center of Accelerator Mass Spectrometry at Lawrence Livermore National Laboratory, and in 2007-2008 he was a visiting scientist at the Counterterrorism and Forensic Science Research Unit in the Laboratory Division of the FBI. He is a member of both the APS DNP and the ACS NUCL Division, and has served as Divisional Councilor since 2012 and as chair of the Coryell Award committee from 2003 to present. He also served on the NAS committee examining the Future of Nuclear and Radiochemistry in the US in 2012 and as co-convener of the 2014 APS Long-Range Planning Town Meeting on Education and Innovation. His research interests include: Heavy ion reactions with radioactive nuclear beams, ion beam analysis and low-background gamma spectroscopy and environmental applications, and most recently radioisotope harvesting from FRIB.

Candidates for Alternate Councilor

Dawn A. Shaughnessy, Lawrence Livermore National Laboratory (, was educated at the University of California, Berkeley (BS, Chemistry, 1993 and Ph.D., Nuclear Chemistry, 2000). She took a postdoctoral appointment at Lawrence Berkeley National Laboratory in 2000. In 2002, she joined the staff at LLNL, where her assignments have included Staff Radiochemist (2002-present); Principal Investigator for Heavy Element Research (2005-present); and Acting Program Element Leader for Stockpile Radiochemistry (2008-2011). In 2011 she was named Group Leader for the newly created Experimental Nuclear and Radiochemistry group and also acts as the Nuclear Science on the National Ignition Facility point of contact. She has served on the Lawrence Berkeley National Laboratory Nuclear Science Education and Wall Chart Committee, 2003-2005; Local Organizing Committee, 2nd International Conference on the Chemistry and Physics of the Transactinides (TAN03), 2002-2003; Interlaboratory Working Group Meeting (ILWOG-39) 2004 Planning Committee, 2003-2004; NNSA Radiochemist Development Working Group, 2004; Interlaboratory Working Group Meeting (ILWOG-40) 2007 Planning Committee (Lead Organizer), 2006-2007; Interlaboratory Working Group Meeting (ILWOG-41) 2008 Planning Committee, 2007-present; LLNL Glenn T. Seaborg Institute (Science Deputy), 2008-present. In the ACS she has co-organized several divisional symposia. Research interests: nuclear and chemical properties of the actinide and trans-actinide elements, spontaneous and delayed fission properties, target preparation and radiochemical separation techniques, radiochemistry at large laser facilities and the behavior of radioactive contaminants in the environment.

Nathalie A. Wall, Washington State University (;, received a maitrîse (B.S. equivalent) in Physical Sciences from the University of Paris (Orsay, France) (1989) and a doctorate in radiochemistry from the University of Paris (Orsay, France) (1993) for her work on actinide chemistry in granitic repository systems. She also worked at the French Atomic Energy Agency (CEA) in the Department for Nuclear Waste Management (1990-1993). During a post-doctoral fellowship at Florida State University (1994-2000) and subsequent appointment at Sandia National Laboratories (2000-2006), she participated to the Compliance Certification and Recertification Applications of the Waste Isolation Pilot Plant (WIPP), the first deep underground repository for TRU wastes. She joined the faculty of the WSU Chemistry Department in 2006, where she held the title of Assistant Research Professor (2006-2008), Clinical Assistant Professor (2008-2009), and Assistant Professor (2009-present). She has been a member of ACS and the NUCL Division since 1996; she co-organized 6 division symposia at ACS national meetings. N. Wall current research focuses on the environmental behavior of radionuclides. Her main goal is to provide valuable data for the detection of nuclear material in the environment, for the remediation of contaminated sites, to ensure the safety of future and existing nuclear waste repositories, and to develop nuclear forensic tools. She is Member of the Distinguished Reviewer Boards for the Journal of Radioanalytical and Nuclear Chemistry (2011-present). She also holds memberships with the Geochemical Society and the Clay Minerals Society.

Candidates for Member-at-Large, Executive Committee

Suzanne E. Lapi, Washington University in St. Louis (, received her Ph.D. in Chemistry from Simon Fraser University for her work conducted at TRIUMF and went on as a post-doctoral scholar at University of California in San Francisco (UCSF) developing agents for Positron Emission Tomography (PET). She is currently an Assistant Professor of Radiology at Washington University in Saint Louis and has appointments in Chemistry, Biochemistry and Biomedical Engineering. As Director of the Washington University Isotope Production Group, she oversees production of metal PET radionuclides for both internal use and for distribution to other academic sites in the United States and Canada. Her research interests are in the development of novel imaging isotopes and translation of new PET imaging agents for oncology and she holds both federal and non-federal grants in this area. She is very interested in moving imaging agents forward to clinical use and she is currently producing isotopes and radiopharmaceuticals for several clinical trials. Dr. Lapi is vice president of the Radiopharmaceutical Sciences Council of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) has been a Board member of the NUCL of the ACS for the past 2 years. She also continues to be a strong advocate of radiopharmaceutical sciences and the training of future radiochemists.

Ralf Sudowe, University of Nevada Las Vegas (, received a M.S. in Chemistry (1995) and a Ph.D. in Nuclear Chemistry (1999) from the Philipps-University Marburg in Germany. He spent two years as Visiting Postdoctoral Fellow in the Nuclear Science Division at Lawrence Berkeley National Laboratory (1999 – 2001) and then became a Staff Scientist in the Nuclear Science and Chemical Sciences Division at LBNL (2001 – 2006). In 2006, he joined the faculty of the Department of Health Physics & Diagnostic Sciences at University of Nevada Las Vegas, where he has held the title of Assistant Professor (2006 – 2012) and Associate Professor (2012 – present). He was appointed Director of the Radiochemistry Ph.D. program at UNLV in 2014 and was granted a joint appointment with the Department of Chemistry and Biochemistry. He has co-organized three divisional symposia at ACS National Meetings as well as a symposium at the ACS Western Regional Meeting. He is a member of the American Chemical Society, the American Nuclear Society and the Health Physics Society.